Pathfinder Cell Therapy (Pathfinder Cell Therapy) FCF Margin % : 0.00% (As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pathfinder Cell Therapy's Free Cash Flow for the three months ended in Sep. 2015 was $-0.18 Mil. Pathfinder Cell Therapy's Revenue for the three months ended in Sep. 2015 was $0.00 Mil. Therefore, Pathfinder Cell Therapy's FCF Margin % for the quarter that ended in Sep. 2015 was 0.00%.

As of today, Pathfinder Cell Therapy's current FCF Yield % is 0.00%.

The historical rank and industry rank for Pathfinder Cell Therapy's FCF Margin % or its related term are showing as below:

PFND's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -141.025
* Ranked among companies with meaningful FCF Margin % only.

Pathfinder Cell Therapy FCF Margin % Historical Data

The historical data trend for Pathfinder Cell Therapy's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy FCF Margin % Chart

Pathfinder Cell Therapy Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

FCF Margin %

Get a 7-Day Free Trial

-3,191.78

-1,775.44

-2,964.81

Pathfinder Cell Therapy Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Pathfinder Cell Therapy's FCF Margin %

For the Biotechnology subindustry, Pathfinder Cell Therapy's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pathfinder Cell Therapy's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pathfinder Cell Therapy's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Pathfinder Cell Therapy's FCF Margin % falls into.

Pathfinder Cell Therapy FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Pathfinder Cell Therapy's FCF Margin for the fiscal year that ended in Dec. 2014 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2014 )	/	Revenue (A: Dec. 2014 )
	=	-0.963	/	0
	=	%

Pathfinder Cell Therapy's FCF Margin for the quarter that ended in Sep. 2015 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2015 )	/	Revenue (Q: Sep. 2015 )
	=	-0.178	/	0
	=	%

Pathfinder Cell Therapy FCF Margin % Related Terms

Thank you for viewing the detailed overview of Pathfinder Cell Therapy's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Bow Street, Cambridge, MA, USA, 02138

Website

http://www.pathfindercelltherapy.com

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

Executives

John J Alam	director	130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks	director	100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines